NextCure, Inc.
NASDAQ:NXTC
0.8225 (USD) • At close January 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 6.284 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22.378 | 2.005 | 1.583 | 1.402 | 1.357 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.701 | 0.94 | 0.824 | 0.946 | 1.086 | 1.11 | 0 | 1.021 | 0 | 2.097 | 2.103 | 2.096 | 1.892 | 1.105 | 12.106 | 12.74 | 11.13 | 10.578 | 11.397 | 8.663 | 7.643 | 6.513 | 6.31 | 4.854 | 4.434 | 4.21 |
| Gross Profit
| 0 | -0.701 | -0.94 | 5.46 | -0.946 | -1.086 | -1.11 | 0 | -1.021 | 0 | -2.097 | -2.103 | -2.096 | -1.892 | -1.105 | -12.106 | -12.74 | -11.13 | 11.8 | -9.392 | -7.08 | -6.241 | -5.156 | -6.31 | -4.854 | -4.434 | -4.21 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0.869 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -540,977,745,999.536 | 0 | 0 | 0.527 | -4.684 | -4.473 | -4.451 | -3.8 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 8.77 | 12.418 | 11.398 | 11.827 | 11.01 | 13.447 | 11.647 | 12.822 | 13.528 | 12.825 | 15.024 | 12.264 | 13.597 | 11.945 | 12.386 | 12.106 | 12.74 | 11.13 | 10.578 | 11.397 | 8.663 | 7.643 | 6.513 | 6.248 | 4.895 | 4.434 | 4.21 |
| General & Administrative Expenses
| 3.725 | 4.076 | 4.364 | 3.963 | 4.608 | 5.711 | 5.424 | 4.949 | 5.711 | 5.303 | 5.747 | 4.807 | 4.911 | 6.007 | 4.848 | 4.131 | 4.659 | 4.671 | 3.588 | 2.618 | 2.622 | 2.714 | 1.659 | 0.819 | 0.925 | 0.866 | 0.799 |
| Selling & Marketing Expenses
| 0 | -0.701 | 3.42 | -0.824 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 3.725 | 3.375 | 3.424 | 3.139 | 4.608 | 5.711 | 5.424 | 4.949 | 5.711 | 5.303 | 5.747 | 4.807 | 4.911 | 6.007 | 4.848 | 4.131 | 4.659 | 4.671 | 3.588 | 2.618 | 2.622 | 2.714 | 1.659 | 0.819 | 0.925 | 0.866 | 0.799 |
| Other Expenses
| 0 | 1.09 | 1.197 | 1.323 | 1.317 | 1.299 | 0.975 | 0 | 0.328 | 0.208 | 0.169 | 0.132 | 0.578 | -0.035 | 0.701 | 0.776 | 1.032 | 1.293 | 1.521 | 1.083 | 1.268 | 0.734 | 0.66 | 0.205 | 0.11 | 0.069 | 0.013 |
| Operating Expenses
| 12.495 | 15.793 | 14.822 | 14.966 | 15.618 | 19.158 | 17.071 | 17.771 | 19.239 | 18.128 | 20.771 | 17.071 | 18.508 | 17.952 | 17.234 | 16.237 | 17.399 | 15.801 | 14.166 | 14.015 | 11.285 | 10.357 | 8.172 | 7.067 | 5.82 | 5.3 | 5.009 |
| Operating Income
| -12.495 | -16.494 | -15.762 | -15.79 | -15.618 | -19.158 | -17.071 | -17.771 | -19.239 | -18.128 | -20.771 | -17.071 | -18.508 | -17.952 | -17.234 | -16.237 | -17.399 | -15.801 | -8.212 | -12.01 | -9.702 | -8.955 | -6.815 | -7.067 | -5.82 | -5.3 | -5.009 |
| Operating Income Ratio
| 0 | 0 | 0 | -2.513 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -725,578,693,359.55 | 0 | 0 | -0.367 | -5.99 | -6.129 | -6.387 | -5.022 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.955 | 1.09 | -1.345 | 1.323 | 1.317 | 1.299 | 0.975 | 0.471 | 0.328 | 0.208 | 0.169 | 0.132 | 0.578 | -0.035 | 0.701 | 0.776 | 1.032 | 1.293 | 1.521 | 1.083 | 1.268 | 0.734 | 0.66 | 0.205 | 0.11 | 0.069 | 0.013 |
| Income Before Tax
| -11.54 | -15.404 | -17.107 | -14.467 | -14.301 | -17.859 | -16.096 | -17.3 | -18.911 | -17.92 | -20.602 | -16.939 | -17.93 | -17.987 | -16.533 | -15.461 | -16.367 | -14.508 | 9.733 | -10.927 | -8.434 | -8.221 | -6.155 | -6.862 | -5.71 | -5.231 | -4.996 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -2.302 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -690,901,778,532.487 | 0 | 0 | 0.435 | -5.45 | -5.328 | -5.864 | -4.536 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.897 | 0.975 | 0.986 | 0.832 | -0.975 | 0 | -0.328 | -0.207 | -0.169 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -11.54 | -15.404 | -17.107 | -14.467 | -14.301 | -17.859 | -15.121 | -17.3 | -18.583 | -17.713 | -20.433 | -16.939 | -17.93 | -17.987 | -16.533 | -15.461 | -16.367 | -14.508 | 9.733 | -10.927 | -8.434 | -8.221 | -6.155 | -6.862 | -5.71 | -5.231 | -4.996 |
| Net Income Ratio
| 0 | 0 | 0 | -2.302 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -690,901,778,532.487 | 0 | 0 | 0.435 | -5.45 | -5.328 | -5.864 | -4.536 | 0 | 0 | 0 | 0 |
| EPS
| -0.41 | -0.55 | -0.61 | -0.52 | -0.51 | -0.64 | -0.54 | 0 | -0.67 | -0.64 | -0.74 | -0.61 | -0.65 | -0.65 | -0.6 | -0.56 | -0.59 | -0.53 | 0.35 | -0.4 | -0.37 | -0.61 | -0.28 | -0.68 | -0.57 | -0.52 | -0.5 |
| EPS Diluted
| -0.41 | -0.55 | -0.61 | -0.52 | -0.51 | -0.64 | -0.54 | 0 | -0.67 | -0.64 | -0.74 | -0.61 | -0.65 | -0.65 | -0.6 | -0.56 | -0.59 | -0.53 | 0.33 | -0.4 | -0.37 | -0.61 | -0.28 | -0.68 | -0.57 | -0.52 | -0.5 |
| EBITDA
| -11.795 | -15.793 | -14.972 | -14.966 | -14.672 | -18.204 | -16.111 | -16.764 | -18.218 | -17.09 | -19.713 | -14.836 | -16.766 | -17.663 | -16.129 | -15.247 | -16.514 | -15.014 | 8.963 | -11.255 | -8.914 | -8.373 | -6.252 | -6.549 | -5.424 | -4.913 | -4.633 |
| EBITDA Ratio
| 0 | 0 | 0 | -2.382 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -681,338,814,907.499 | 0 | 0 | 0.401 | -5.613 | -5.631 | -5.972 | -4.607 | 0 | 0 | 0 | 0 |